KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Net Margin: 2010-2024

Historic Net Margin for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to 7.44%.

  • TherapeuticsMD's Net Margin rose 2069.00% to 13.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.19%, marking a year-over-year decrease of 3260.00%. This contributed to the annual value of 7.44% for FY2024, which is 20552.00% up from last year.
  • TherapeuticsMD's Net Margin amounted to 7.44% in FY2024, which was up 103.76% from -198.08% recorded in FY2023.
  • TherapeuticsMD's 5-year Net Margin high stood at 158.55% for FY2022, and its period low was -3,618.73% during FY2021.
  • Over the past 3 years, TherapeuticsMD's median Net Margin value was 7.44% (recorded in 2024), while the average stood at -10.70%.
  • Per our database at Business Quant, TherapeuticsMD's Net Margin slumped by 333,583bps in 2021 and then skyrocketed by 377,728bps in 2022.
  • Over the past 5 years, TherapeuticsMD's Net Margin (Yearly) stood at -282.90% in 2020, then crashed by 333,583bps to -3,618.73% in 2021, then spiked by 377,728bps to 158.55% in 2022, then tumbled by 35,663bps to -198.08% in 2023, then skyrocketed by 20,552bps to 7.44% in 2024.